Total ischemic time and age as predictors of PCI failure in STEMIs: A systematic review

Samantha R Kennedy1, Yunki Kim1, Scott Martin2

  • 1Sacred Heart University, Fairfield, CT, USA.

Insights

Older patients and longer ischemic times increase the risk of coronary no-reflow after primary percutaneous coronary intervention (PCI). This phenomenon hinders cardiac tissue reperfusion, necessitating new guidelines and research for improved outcomes in ST-elevation myocardial infarction (STEMI) patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Myocardial Infarction Research

Background:

  • Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-elevation myocardial infarction (STEMI).
  • Cardiac tissue reperfusion after primary PCI is not always achieved, leading to the "no-reflow" phenomenon.
  • Factors influencing no-reflow, such as ischemic time and patient age, require systematic investigation.

Purpose of the Study:

  • To systematically evaluate the predictive values of total ischemic time and patient age for coronary no-reflow.
  • To assess the association between advanced age and prolonged ischemia with no-reflow post-primary PCI.

Main Methods:

  • Systematic literature search across multiple databases (EBSCOhost, Cochrane).
  • Screening, selection, and data extraction by two independent reviewers using Covidence.org.
  • Quality assessment of eight selected cohort studies using the Newcastle-Ottawa Scale.

Main Results:

  • The review included eight studies with 7060 participants.
  • Patients over 60 years old had 1.53-2.53 times higher odds of experiencing no-reflow.
  • Increased total ischemic time correlated with 1.147-4.655 times higher odds of no-reflow incidence.

Conclusions:

  • Patients over 60 with ischemic times exceeding 4-6 hours face a heightened risk of PCI failure due to no-reflow.
  • Improved coronary reperfusion after primary PCI requires novel guidelines and further research into preventing and treating no-reflow.
  • Identifying high-risk patients can guide interventions to mitigate no-reflow complications.
Abstract